PharmiWeb.com - Global Pharma News & Resources
30-Apr-2020

MOLOGEN AG: Resignation of all Management and Supervisory Board members

MOLOGEN AG / Key word(s): Personnel
MOLOGEN AG: Resignation of all Management and Supervisory Board members

30-Apr-2020 / 20:29 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Mologen AG: resignation of all Management and Supervisory Board members

 

The members of the Management Board of Mologen AG (WKN A2LQ90), Dr. Stefan Manth and Dr. Matthias Baumann, resigned from their positions with effect as of the end of April 30, 2020.

The members of the Supervisory Board, Mr. Oliver Krautscheid and Dr. Michael Schulz, have informed the Management Board that they resign from their positions with effect as of July 30, 2020. Dr. Friederike Zahm has informed the Management Board that she resigns from her Supervisory Board position with effect as of July 31, 2020.


Contact:
Christian Köhler-Ma
Insolvenzverwalter der Mologen AG
+49 (0) 30 / 700 171 500
info@gtrestructuring.com


30-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MOLOGEN AG
Königin-Luise-Str. 27
14195 Berlin
Germany
Phone: 030 / 841788-0
Fax: 030 / 841788-50
E-mail: presse@mologen.com
Internet: www.mologen.com
ISIN: DE000A2LQ900
WKN: A2LQ90
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1034671

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 30-Apr-2020